Tiffany N Seagroves

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 8

Top Venues

Cancer research

Cancers

Molecular cancer therapeutics

Molecular cancer research : MCR

University of Tennessee Health Science Center

Baylor College of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Tennessee Health Science Center

United States

Professor :: Pathology and Laboratory Medicine

Education History

Baylor College of Medicine

United States

PHD :: Molecular and Cell Biology

University of North Carolina System

United States

BSC

Publications

Shanshan Deng, Raisa I Krutilina, Kelli L Hartman, Hao Chen, Deanna N Parke, Rui Wang, Sasha H Shafikhani, Dejian Ma, Pradeep B Lukka, Bernd Meibohm, Tiffany N Seagroves, Duane D Miller, Wei Li
Colchicine-Binding Site Agent CH-2-77 as a Potent Tubulin Inhibitor Suppressing Triple-Negative Breast Cancer. Molecular cancer therapeutics 21 (7) (2022)
Raisa I Krutilina, Kelli L Hartman, Damilola Oluwalana, Hilaire C Playa, Deanna N Parke, Hao Chen, Duane D Miller, Wei Li, Tiffany N Seagroves
Sabizabulin, a Potent Orally Bioavailable Colchicine Binding Site Agent, Suppresses HER2+ Breast Cancer and Metastasis. Cancers 14 (21) (2022)
Raisa I Krutilina, Hilaire Playa, Danielle L Brooks, Luciana P Schwab, Deanna N Parke, Damilola Oluwalana, Douglas R Layman, Meiyun Fan, Daniel L Johnson, Junming Yue, Heather S Smallwood, Tiffany N Seagroves
HIF-Dependent CKB Expression Promotes Breast Cancer Metastasis, Whereas Cyclocreatine Therapy Impairs Cellular Invasion and Improves Chemotherapy Efficacy. Cancers 14 (1) (2021)
Amy R Dwyer, Carlos Perez Kerkvliet, Raisa I Krutilina, Hilaire C Playa, Deanna N Parke, Warner A Thomas, Branden A Smeester, Branden S Moriarity, Tiffany N Seagroves, Carol A Lange
Breast Tumor Kinase (Brk/PTK6) Mediates Advanced Cancer Phenotypes via SH2-Domain Dependent Activation of RhoA and Aryl Hydrocarbon Receptor (AhR) Signaling. Molecular cancer research : MCR 19 (2) (2020)
Shanshan Deng, Raisa I Krutilina, Qinghui Wang, Zongtao Lin, Deanna N Parke, Hilaire C Playa, Hao Chen, Duane D Miller, Tiffany N Seagroves, Wei Li
An Orally Available Tubulin Inhibitor, VERU-111, Suppresses Triple-Negative Breast Cancer Tumor Growth and Metastasis and Bypasses Taxane Resistance. Molecular cancer therapeutics 19 (2) (2019)
Kinsie E Arnst, Yuxi Wang, Zi-Ning Lei, Dong-Jin Hwang, Gyanendra Kumar, Dejian Ma, Deanna N Parke, Qiang Chen, Jinliang Yang, Stephen W White, Tiffany N Seagroves, Zhe-Sheng Chen, Duane D Miller, Wei Li
Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor Efficacy. Molecular pharmacology 96 (1) (2019)
Maria Angeles Lillo Osuna, Jesus Garcia-Lopez, Ikbale El Ayachi, Iram Fatima, Aysha B Khalid, Jerusha Kumpati, Alexandria V Slayden, Tiffany N Seagroves, Gustavo A Miranda-Carboni, Susan A Krum
Activation of Estrogen Receptor Alpha by Decitabine Inhibits Osteosarcoma Growth and Metastasis. Cancer research 79 (6) (2018)
Ikbale El Ayachi, Iram Fatima, Peter Wend, Jackelyn A Alva-Ornelas, Stephanie Runke, William L Kuenzinger, Julio Silva, Wendy Silva, Joseph K Gray, Stephan Lehr, Hilaire C Barch, Raisa I Krutilina, Andrew C White, Robert D Cardiff, Lisa D Yee, Lily Yang, Ruth M O'Regan, William E Lowry, Tiffany N Seagroves, Victoria Seewaldt, Susan A Krum, Gustavo A Miranda-Carboni
The WNT10B Network Is Associated with Survival and Metastases in Chemoresistant Triple-Negative Breast Cancer. Cancer research 79 (5) (2018)

Tiffany N Seagroves.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tiffany N Seagroves